Market Value202,279,540
Total Holdings44
File Date2023-05-12
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
CNC / Centene Corporation
ABC / Amerisource Bergen Corp.
AGLE / Aeglea BioTherapeutics Inc
RETA / Reata Pharmaceuticals Inc - Class A Put
CNTB / Connect Biopharma Holdings Limited - Depositary Receipt (Common Stock)
RLMD / Relmada Therapeutics, Inc.
RLMD / Relmada Therapeutics, Inc. Put
EUCRU / Eucrates Biomedical Acquisition Corp
SIENQ / Sientra, Inc.
GEHC / GE HealthCare Technologies Inc.
HSKA / Heska Corp. (Restricted Voting)
ICLR / ICON Public Limited Company
SIEN / Sientra, Inc.
OGN / Organon & Co.
CRBP / Corbus Pharmaceuticals Holdings, Inc.
ASLN / ASLAN Pharmaceuticals Limited - Depositary Receipt (Common Stock)
CI / The Cigna Group
VINC / Vincerx Pharma, Inc.
NLTX / Neoleukin Therapeutics, Inc.
RXDX / Prometheus Biosciences Inc Put
HSAQ / Health Sciences Acquisitions Corp 2
AVTR / Avantor, Inc.
FUSN / Fusion Pharmaceuticals Inc.
DGX / Quest Diagnostics Incorporated Put
MBRX / Moleculin Biotech, Inc.
MSAC / Medicus Sciences Acquisition Corp - Class A
NVAX / Novavax, Inc.
STAA / STAAR Surgical Company
IDYA / IDEAYA Biosciences, Inc.
MRUS / Merus N.V.
RCKTW / Rocket Pharmaceuticals, Inc. - Equity Warrant
NYXH / Nyxoah SA
MODD / Modular Medical, Inc.
PTGX / Protagonist Therapeutics, Inc.
HUMA / Humacyte, Inc.
RVMD / Revolution Medicines, Inc.
ADCT / ADC Therapeutics SA
NVCN / Neovasc Inc
CTIC / CTI BioPharma Corp
CBAY / CymaBay Therapeutics, Inc.
INGN / Inogen, Inc.
UTHR / United Therapeutics Corporation
CMAX / CareMax, Inc.
VKTX / Viking Therapeutics, Inc.
ISEE / IVERIC bio Inc Put
VNDA / Vanda Pharmaceuticals Inc.
ASLN / ASLAN Pharmaceuticals Limited - Depositary Receipt (Common Stock)
HUMAW / Humacyte, Inc. - Equity Warrant
ELEV / Elevation Oncology, Inc.
GMED / Globus Medical, Inc.
MACK / Merrimack Pharmaceuticals, Inc.
CMAXW / CareMax Inc - Warrants (08/06/2026)
APRE / Aprea Therapeutics, Inc.
MDT / Medtronic plc
SVRA / Savara Inc.
PHVS / Pharvaris N.V.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
TYRA / Tyra Biosciences, Inc.
XFOR / X4 Pharmaceuticals, Inc.
AXNX / Axonics, Inc.
RPTX / Repare Therapeutics Inc.
RLAY / Relay Therapeutics, Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
NXTC / NextCure, Inc.